KARD vs MLYS: stock comparison and AI forecast
Kardigan, Inc. (KARD) and Mineralys Therapeutics, Inc. (MLYS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KARD Kardigan, Inc.
- Price
- $14.21 -35.6% · 6M
- Market Cap
- $1.34B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MLYS Mineralys Therapeutics, Inc.
- Price
- $15.99 -45.4% · 6M
- Market Cap
- $1.41B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KARD and MLYS have similar market capitalizations ($1.34B and $1.41B).
- Over the last six months KARD returned -35.6% and MLYS -45.4%.
- MLYS carries 0.21 times debt per unit of equity, against 0.17 times for KARD.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KARD | MLYS |
|---|---|---|
| Market Cap | $1.34B | $1.41B |
| P/B Ratio | 2.18x | 2.57x |
| EPS | – | $-4.48 |
| Book Value/Share | $6.58 | $6.23 |
Profitability & Margins
| Metric | KARD | MLYS |
|---|---|---|
| ROE | – | -63.5% |
| ROA | – | -52.3% |
| ROIC | – | -57.2% |
Financial Health
| Metric | KARD | MLYS |
|---|---|---|
| Current Ratio | 8.72x | 34.46x |
| D/E Ratio | 0.17x | 0.21x |
| Financial Leverage | 1.17x | 1.21x |
| Working Capital | $540M | $646M |
Cash Flow
| Metric | KARD | MLYS |
|---|---|---|
| Operating Cash Flow | – | -$139M |
Income Statement
| Metric | KARD | MLYS |
|---|---|---|
| Operating Income | – | -$371M |
| Net Income | – | -$350M |
| R&D Expense | – | $302M |
Dividend & Shareholder Information
| Metric | KARD | MLYS |
|---|---|---|
| Shares Outstanding | 94M | 88M |
KARD vs MLYS: stock comparison and AI forecast
Which is bigger, KARD or MLYS?
KARD and MLYS have similar market capitalizations ($1.34B and $1.41B).
Which stock performed better over the last six months, KARD or MLYS?
Over the last six months KARD returned -35.6% and MLYS -45.4%.
Which one does Intratio's AI model rank higher, KARD or MLYS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.